Literature DB >> 19407465

Necrotizing enterocolitis--150 years of fruitless search for the cause.

Michael Obladen1.   

Abstract

Necrotizing enterocolitis (NEC) is not a new disease but one that has been reported since special care units began to house preterm infants. It was observed in foundling hospitals in Paris [Billard, 1828] and Vienna [Bednar, 1850] and, as it occurred in clusters, was regarded as a nosocomial infection in the infant hospitals of Zurich [Willi, 1944] and Berlin [Ylppo, 1931]. Clinical and patho-anatomic characterization was achieved by Schmidt and Quaiser in 1952. The unproven hypothesis of mesenteric hypoperfusion as a major etiological factor arose from animal models and analogous perforating disorders in term infants. Despite similarities between NEC and clostridial infections, few studies employed anaerobic culture techniques. The pathogenesis remains unclear and its distinction from related disorders uncertain. It is unlikely that strategies to prevent NEC will be successful unless the disease is better understood. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19407465     DOI: 10.1159/000215590

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  32 in total

Review 1.  Primary anastomosis or ostomy in necrotizing enterocolitis?

Authors:  Ramanathapura N Haricharan; Jade Palazzola Gallimore; Ahmed Nasr
Journal:  Pediatr Surg Int       Date:  2017-08-02       Impact factor: 1.827

2.  Cyclosporine treatment improves mesenteric perfusion and attenuates necrotizing enterocolitis (NEC)-like intestinal injury in asphyxiated newborn piglets during reoxygenation.

Authors:  Richdeep S Gill; Namdar Manouchehri; Tze-Fun Lee; Woo Jung Cho; Aducio Thiesen; Thomas Churchill; David L Bigam; Po-Yin Cheung
Journal:  Intensive Care Med       Date:  2011-12-06       Impact factor: 17.440

Review 3.  Probiotics and necrotizing enterocolitis.

Authors:  Josef Neu
Journal:  Clin Perinatol       Date:  2014-09-30       Impact factor: 3.430

Review 4.  Standardized feeding regimen for reducing necrotizing enterocolitis in preterm infants: an updated systematic review.

Authors:  B Jasani; S Patole
Journal:  J Perinatol       Date:  2017-03-30       Impact factor: 2.521

5.  Routine probiotics for premature infants: let's be careful!

Authors:  Josef Neu
Journal:  J Pediatr       Date:  2011-01-08       Impact factor: 4.406

6.  Do red cell transfusions increase the risk of necrotizing enterocolitis in premature infants?

Authors:  Cassandra D Josephson; Agnieszka Wesolowski; Gaobin Bao; Martha C Sola-Visner; Golde Dudell; Marta-Inés Castillejo; Beth H Shaz; Kirk A Easley; Christopher D Hillyer; Akhil Maheshwari
Journal:  J Pediatr       Date:  2010-07-21       Impact factor: 4.406

7.  The T1405N carbamoyl phosphate synthetase polymorphism does not affect plasma arginine concentrations in preterm infants.

Authors:  Rob M J Moonen; Iballa Reyes; Giacomo Cavallaro; Gema González-Luis; Jaap A Bakker; Eduardo Villamor
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

8.  Intestinal alkaline phosphatase prevents the systemic inflammatory response associated with necrotizing enterocolitis.

Authors:  Kevin M Riggle; Rebecca M Rentea; Scott R Welak; Kirkwood A Pritchard; Keith T Oldham; David M Gourlay
Journal:  J Surg Res       Date:  2012-11-08       Impact factor: 2.192

9.  The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine.

Authors:  Misty Good; Chhinder P Sodhi; Yukihiro Yamaguchi; Hongpeng Jia; Peng Lu; William B Fulton; Laura Y Martin; Thomas Prindle; Diego F Nino; Qinjie Zhou; Congrong Ma; John A Ozolek; Rachael H Buck; Karen C Goehring; David J Hackam
Journal:  Br J Nutr       Date:  2016-09-09       Impact factor: 3.718

Review 10.  Paneth cells and necrotizing enterocolitis: a novel hypothesis for disease pathogenesis.

Authors:  Steven J McElroy; Mark A Underwood; Michael P Sherman
Journal:  Neonatology       Date:  2012-09-20       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.